John Ronald Jeffrey Jr.
John Ronald Jeffrey Jr.: Director at Argan. What John Ronald Jeffrey Jr. holds in an AI or semiconductor company tracked on Silicon Floor, from their SEC filings, broken down: the shares held and how, then any restricted shares, options or other rights declared.
Argan (AGX)
John Ronald Jeffrey Jr. holds 10,533 Argan shares (0.08% of the company), worth about $4.3M at the last price, according to the Form 4 of Jul 31, 2026.
- Shares held: 8,000 (0.06%), $3.3M — Held in a retirement account (John R. Jeffrey, IRA).
- Shares held: 2,533 (0.02%), $1.0M — Held in their own name.
- Options: 31,500 (0.22%), $12.8M — The right to buy 31,500 shares at $41.19 each, until 2028. Not bought yet.
- Options: 21,500 (0.15%), $8.7M — The right to buy 21,500 shares at $40.15 each, until 2029. Not bought yet.
- Options: 11,500 (0.08%), $4.7M — The right to buy 11,500 shares at $45.75 each, until 2030. Not bought yet.
- Options: 6,500 (0.05%), $2.6M — The right to buy 6,500 shares at $37.13 each, until 2031. Not bought yet.
- Options: 1,500 (0.01%), $609,960.00 — The right to buy 1,500 shares at $35.72 each, until 2032. Not bought yet.
- Share units: 1,023 (0.01%), $415,992.72 — Argan promised them as pay: each unit becomes a share when it vests, if its conditions are met. No vote until then.
- Options: 500 (0.00%), $203,320.00 — The right to buy 500 shares at $43.70 each, until 2033. Not bought yet.
Declarations
- Argan (AGX) — Form 4 of Jul 31, 2026: open-market sale of 5,716 at $579.64; 10,533 shares after 0001709914-26-000028
- Argan (AGX) — Form 4 of Jun 30, 2026: option exercise or conversion of 4,772 at $35.72; option exercise or conversion of 944 at $43.70; 16,249 shares after 0001709914-26-000024
- Argan (AGX) — Form 4 of Jun 10, 2026: option exercise or conversion of 533; 10,533 shares after 0001709914-26-000022
- Argan (AGX) — Form 4 of Apr 27, 2026: open-market sale of 2,698 at $664.84; 10,000 shares after 0001709914-26-000020
- Argan (AGX) — Form 4 of Apr 21, 2026: open-market sale of 3,636 at $615.40; option exercise or conversion of 4,698 at $37.13; 12,698 shares after 0001709914-26-000016
- Argan (AGX) — Form 4 of Mar 31, 2026: open-market sale of 4,556 at $539.85; 11,636 shares after 0001709914-26-000012
- Argan (AGX) — Form 4 of Jan 27, 2026: open-market sale of 5,000 at $360.78; 16,192 shares after 0001709914-26-000008
- Argan (AGX) — Form 4 of Jan 20, 2026: option exercise or conversion of 8,636 at $45.75; open-market sale of 2,700 at $380.60; 21,192 shares after 0001709914-26-000004
- Argan (AGX) — Form 4 of Dec 16, 2025: option exercise or conversion of 856; option exercise or conversion of 1,844; 15,256 shares after 0001709914-25-000009
- Argan (AGX) — Form 4 of Sep 29, 2025: open-market sale of 4,698 at $268.60; 12,556 shares after 0001709914-25-000007
- Argan (AGX) — Form 4 of Jul 29, 2025: open-market sale of 2,621 at $235.63; 9,254 shares after 0001415889-25-020719
- Argan (AGX) — Form 4 of Jun 17, 2025 0001415889-25-017831
- Argan (AGX) — Form 4 of Jun 10, 2025: open-market sale of 5,500 at $217.79; option exercise or conversion of 390; 19,875 shares after 0001415889-25-016656
- Argan (AGX) — Form 4 of Jan 17, 2025: option exercise or conversion of 7,731 at $40.15; 24,985 shares after 0001415889-25-001850
- Argan (AGX) — Form 4 of Dec 31, 2024: open-market sale of 5,000 at $138.99; 17,254 shares after 0001415889-25-000399
Sources: SEC Schedules 13D and 13G (stakes above 5%, which count everything a person votes or can acquire within 60 days) and Forms 3, 4 and 5 (the shares a director, officer or 10% owner holds, filed within two business days of each trade). Values at the last price.